Neuberger Berman Group LLC Axsome Therapeutics, Inc. Transaction History

Neuberger Berman Group LLC

$123 Billion
Q3 2024

A detailed history of Neuberger Berman Group LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 80,014 shares of AXSM stock, worth $7.26 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

80,014

Previous 74,767 7.02%

Holding current value

$7.26 Million

Previous $6.02 Million 19.46%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$78.93 - $95.84 $414,145 - $502,872	5,247 Added 7.02%	80,014 $7.19 Million
Q2 2024 Nov 14, 2024	SELL	$65.72 - $80.5 $1.11 Million - $1.36 Million	-16,889 Reduced 18.43%	74,767 $6.02 Million
Q2 2024 Aug 13, 2024	SELL	$65.72 - $80.5 $1.11 Million - $1.36 Million	-16,889 Reduced 18.43%	74,767 $6.02 Million
Q1 2024 Nov 14, 2024	BUY	$69.39 - $97.64 $3.28 Million - $4.62 Million	47,341 Added 106.83%	91,656 $7.31 Million
Q1 2024 May 13, 2024	BUY	$69.39 - $97.64 $6.36 Million - $8.95 Million	91,656 New	91,656 $7.31 Million
Q4 2023 Nov 14, 2024	SELL	$57.42 - $83.61 $1.75 Million - $2.55 Million	-30,452 Reduced 40.73%	44,315 $3.53 Million
Q4 2023 Feb 09, 2024	BUY	$57.42 - $83.61 $2.54 Million - $3.71 Million	44,315 New	44,315 $3.53 Million
Q4 2020 Feb 10, 2021	SELL	$66.31 - $86.52 $2.29 Million - $2.98 Million	-34,500 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$68.34 - $85.84 $478,380 - $600,880	7,000 Added 25.45%	34,500 $2.46 Million
Q2 2020 Aug 13, 2020	BUY	$49.87 - $98.69 $548,570 - $1.09 Million	11,000 Added 66.67%	27,500 $2.26 Million
Q1 2020 May 14, 2020	SELL	$41.2 - $101.31 $144,200 - $354,585	-3,500 Reduced 17.5%	16,500 $970,000
Q4 2019 Feb 12, 2020	SELL	$16.71 - $106.24 $215,559 - $1.37 Million	-12,900 Reduced 39.21%	20,000 $2.07 Million
Q3 2019 Nov 13, 2019	BUY	$20.24 - $29.16 $70,840 - $102,060	3,500 Added 11.9%	32,900 $666,000
Q2 2019 Aug 13, 2019	SELL	$13.46 - $25.75 $169,596 - $324,450	-12,600 Reduced 30.0%	29,400 $757,000
Q1 2019 May 13, 2019	BUY	$2.63 - $16.34 $110,460 - $686,280	42,000 New	42,000 $598,000

Others Institutions Holding AXSM

# of Institutions

325

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Axsome Therapeutics, Inc. Transaction History